← Back to Search

Corticosteroid

H.P. ACTHAR GEL for Vasculitis

Phase 4
Waitlist Available
Research Sponsored by Ocular Immunology and Uveitis Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Summary

This trial will study the effects of Acthar on adults with a non-infectious form of eye inflammation.

Eligible Conditions
  • Vasculitis
  • Posterior Uveitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of responders to Acthar at the end of treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: H.P. ACTHAR GELExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Ocular Immunology and Uveitis FoundationLead Sponsor
~5 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top